Driving innovation is in our blood, so the promise of potential breakthroughs can reach our patients. Supporting patients and those who treat them is our honor, our responsibility, and our passion.
See how Pfizer Oncology is committed to making innovative advancements in Hematology/Oncology.
As we work to advance the science in leukemia, multiple myeloma, and lymphoma, Pfizer Oncology is committed to partnering with patient, caregiver, and scientific communities to provide information and resources to help improve patient care.
Select blood cancer type:
PATIENT/CAREGIVER
Caring For Your Loved One, and Yourself
Learn from Carri, who cares for her partner living with multiple myeloma, as she speaks with Dr. Craig Cole, from Michigan State University Karmanos Cancer Institute, and Nikki Yuill, from the Leukemia & Lymphoma Society, about how she nurtures her mental well-being. For more support and resources for patients and care partners, visit the Leukemia & Lymphoma Society (LLS) website at: Patient Support | Leukemia and Lymphoma Society (lls.org).
Healthcare provider
Disparities exist in multiple myeloma incidence and outcomes, partly because of sociodemographic factors such as age, sex, race/ethnicity, and more.
As improvements in multiple myeloma treatment continue developing, it is important to further explore disparities among patients in order to ensure equitable treatment for all. In this article, the impact of sociodemographic factors on outcomes in patients with multiple myeloma were assessed, with the aim of informing future areas of research to improve access to equitable care.
Read more
Healthcare provider
What are the experiences of working-age people who have been treated for multiple myeloma, and their family members?
While research on the impact of cancer on employment is vast and growing, there has been a limited focus on working-age adults with multiple myeloma to understand the disease’s effect on work-related experiences. This article aims to synthesize the qualitative evidence pertaining to these experiences in multiple myeloma patients and their family members.
Read more
Healthcare provider
Acute lymphoblastic leukemia (ALL) patients experience a significant symptom burden that impacts their lives in many different ways.
As new treatments emerge and their uptake increases, it is important to better understand the impact of ALL symptoms and treatments on patients’ quality of life. In this study, patient-reported information shared on social media was analyzed in order to contextualize emergent themes in patient experiences with ALL, with the aim of being able to inform the development of novel therapies.
Learn more
PATIENT/CAREGIVER
This Is Living With Cancer®: Multiple Myeloma is a free online resource for patients living with multiple myeloma and their caregivers.
It features tips on disease management, fitness, nutrition, and emotional well-being, as well as informative articles on treatment and clinical trials. Additionally, visitors to the site can connect with reputable support services and multiple myeloma advocacy groups.
Learn more
LivingWith® is a free app developed by Pfizer Oncology for people living with cancer and those who love them. Designed to help you connect with loved ones, ask for the support you need, remember important information from doctors’ visits, and stay organized, all in one place.
Available in English and Spanish. Download LivingWith® for free.
App Store is a service mark of Apple Inc., registered in the U.S. and other countries. Google Play and the Google Play logo are trademarks of Google LLC.
Healthcare provider
There is a growing and urgent global demand for the continued education of hematologists across various aspects of clinical practice.
The International Academy for Clinical Hematology (IACH) is founded by a group of physicians whose aim is to create a comprehensive intellectual and operational environment for the acquisition of knowledge, skills, and clinical judgment essential for the practice of hematology.
Learn more
PATIENT/CAREGIVER
Watch as Pfizer's collection of videos under the Leukaemia Foundation video project tackles important aspects of the patient and caregiver journey, including the physical and emotional toll of the disease and its impact on relationships.
In My Shoes
Watch as Alastair discusses how he learned about his diagnosis of acute lymphoblastic leukemia (ALL) and his advice for dealing with the disease.
Emotional and Mental Health
Jaime, a patient with acute myeloid leukemia (AML), details how the disease has had an impact on his mental health, the challenges he’s faced since diagnosis, and a key piece of advice he was given.
Physical Changes and Fatigue
Watch as Jaime continues to discuss living with AML, this time pertaining to the physical tax of therapy and dealing with fatigue.
Relationships and Friendships
Hear Jaime continue his story as he details the changes AML had on his closest relationships in life and how support systems began to form.
The Role of a Caregiver
Leanne discusses her role as a caregiver to her husband Jaime after his diagnosis with AML, including how she stays positive.
PATIENT/CAREGIVER
Myeloma, or multiple myeloma, is the second most common blood cancer and most often presents among people aged over 65.
Being diagnosed with this disease will likely come with many questions. What is myeloma? What causes it? What are the symptoms? Myeloma Patients Europe (MPE) can help answer most of your questions on how the disease will impact your everyday life.
Learn more
MPE has permitted Pfizer Inc. the use of their resources and logo; however, they do not endorse the entirety of this website.
Healthcare provider
Myeloma, also known as multiple myeloma, is a rare cancer that accounts for roughly 1% of all cancer diagnoses worldwide.
One of Myeloma Patients Europe’s (MPE) strategic objectives is to expedite diagnosis and treatment. The Myeloma Diagnosis Pathway chart can help you recognize the signs and symptoms of myeloma and provides steps to follow if you suspect the disease in your patients.
View now
Continue learning by visiting MPE’s video page, which includes educational clips on myeloma and amyloid light-chain (AL) amyloidosis, as well as details about the MPE Year of Action on Diagnosis.
Watch now
MPE has permitted Pfizer Inc. the use of their resources and logo; however, they do not endorse the entirety of this website.
PATIENT/CAREGIVER
Preparing ahead may help you make the most of your time with your healthcare team.
Because multiple myeloma can be a challenge to manage, it can be hard to keep track of everything you want to talk about, from treatment to travel to mental health. Use this checklist of suggested questions to help remember what’s most important to you to discuss in your next appointment.
Download the checklist
PATIENT/CAREGIVER
Navigating a life-threatening disease can be especially challenging on children and their families. Be The Match® introduces the Ava + Bo series—an educational animated series that helps kids and teens understand bone marrow transplants and what to expect.
The main character Ava got a bone marrow transplant for leukemia as a child. Now as a young teen, she shares her experience and brings her favorite stuffed animal Bo along for the ride. The series aims to make it easier to talk to your child about what they are going through during diagnoses and the transplant process. You can watch episodes together and discuss them with your family on the Be The Match® website.
View episodes
PATIENT/CAREGIVER
Finding clinical trials that support you can be difficult to navigate. The Be The Match® Jason Carter Clinical Trials Search & Support program was created to help people with blood cancers or blood disorders to learn more about relevant clinical trials. Through one-on-one support, Be The Match® can help you learn about treatment options, answer your questions, and understand your rights when participating in a clinical trial. Visit the Be The Match® website to discover your one-stop shop for clinical trials and support for blood cancers and disorders.
Explore clinical trials
PATIENT/CAREGIVER
Multiple myeloma may present many difficulties, but understanding the language associated with it can be helpful. The International Myeloma Foundation (IMF) glossary can help you get familiarized with important terms and definitions.
Click here to view the IMF’s terms and definitions sheet
The IMF is devoted to advancing research toward prevention and a cure for multiple myeloma. The IMF strives to improve the quality of life for those impacted by the disease through patient education, support, and advocacy programs.
Find out more about IMF
HEALTHCARE PROVIDER
MRD, referred to as measurable or minimal residual disease, negativity is a promising surrogate endpoint for multiple myeloma clinical trials. Dr. Jeffrey Wolf, from the Helen Diller Family Comprehensive Cancer Center at the University of California San Francisco, explains what MRD is and how providers can explain the role of MRD to patients. Hear Dr. Wolf speak to the tests used, how to counsel patients about MRD, use of MRD test results in the future, and so much more.
Please click here to listen to this podcast on The LLS site
HEALTHCARE PROVIDER
Advancements in outpatient care and increased awareness of the impact of in-patient stays on patients has called for the reevaluation of prolonged hospitalization following induction chemotherapy for acute myeloid leukemia (AML) or other high-grade myeloid neoplasms.
This study, found on the Journal of the National Comprehensive Cancer Network (JNCCN) website, examines the safety and impact on healthcare resource utilization of early hospital discharge in patients with AML or other high-grade myeloid neoplasms being treated with induction chemotherapy. The article reports an institution’s experiences with early hospital discharge over a 4-year period to draw its conclusions.
Click here to view the full article on the JNCCN website
HEALTHCARE PROVIDER
Pfizer is proud of its contribution to the Association of Community Cancer Centers (ACCC) and Harborside’s virtual summit to define the role of Oncology advanced practitioners in equitable cancer care delivery. Over the course of 3 days, a coalition of advanced practitioners came together to discuss what they can do to help promote healthcare equity, including in-depth dialogues on care coordination and communication, clinical trials, and acknowledging and mitigating implicit bias.
Click here to view the full executive summary and report
PATIENT/CAREGIVER
This Is Living With Cancer® is a free online resource developed by Pfizer Oncology for all people living with cancer, regardless of tumor type or stage of disease. This program is available to anyone in the United States, whether they’re currently on a Pfizer treatment or not. Topics include:
Visit ThisIsLivingWithCancer.com to learn more
LivingWith® is a free app developed by Pfizer Oncology for people living with cancer and those who love them. Designed to help you connect with loved ones, ask for the support you need, remember important information from doctors’ visits, and stay organized, all in one place.
Available in English and Spanish. Download LivingWith® for free.
App Store is a service mark of Apple Inc., registered in the U.S. and other countries. Google Play and the Google Play logo are trademarks of Google LLC.
Watch a video about This Is Living With Cancer®
HEALTHCARE PROVIDER
Healthcare disparities are a known factor in cancer care. Understanding these disparities can enable healthcare professionals to more effectively communicate with and treat their patients. In this episode, Dr. Justine Kahn, from the Herbert Irving Comprehensive Cancer Center at Columbia University Irving Medical Center in New York City, defines and describes existing healthcare disparities, addresses ways to eliminate disparities, underscores the impact of insurance, and discusses the importance of enhancing awareness among primary care healthcare professionals to reduce challenges that lead to delayed diagnoses.
Please click here to listen to this podcast on The LLS site
PATIENT/CAREGIVER
Chronic Myeloid Leukemia (CML) can be a challenging disease to manage, but preparing for appointments with a care team can help. Have you thought about what questions to ask, what information to have prepared that can be helpful, and/or goals you may have? This prep sheet can help you get the most out of your next appointment by taking you through symptoms, treatment options, side effects, and getting the emotional and practical support you need.
Click here to download the CML prep sheet
Together with the Hematology/Oncology community, we are dedicated to making meaningful change for people living with blood cancer. Our work is far from over…
Breakthroughs that change patients’ lives®
